The relationship between serum rheumatoid factor level and no‐reflow phenomenon in patients with acute <scp>ST</scp>‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Quisi, Alaa; Alıcı, Gökhan

doi:10.1002/jcla.22598

Cited by 6 publications

(4 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It should be noted, nonetheless, that a wide variety of demographic, laboratory, and procedural factors have been proven to influence the development of NR. [20][21][22][23][24] Several studies have shown a link between AF-related stroke risk scoring systems, which are often used in cardiology, and NR in acute MI patients. Independent of AF and stroke risks, the impact of stroke risk scoring system components on coronary artery events was also examined.…”

Section: Discussionmentioning

confidence: 99%

Impact of HAT₂CH₂ Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

et al. 2023

Self Cite

View full text Add to dashboard Cite

The HAT2CH2 score [Hypertension (1 point), Age > 75 years (1 point), Stroke/Transient ischemic attack (2 points), Chronic obstructive pulmonary disease (1 point), and Heart failure (2 points)] was originally developed to predict the occurrence of new-onset atrial fibrillation. The aim of the present study was to examine whether this score could predict the development of no-reflow phenomenon (NR) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). Patients (n = 1552) with STEMI were consecutively enrolled in this single-center retrospective study. The SYNTAX score (SXscore) and HAT2CH2 score were calculated. The presence of thrombolysis in myocardial infarction (TIMI) score ≤2, without significant residual stenosis and mechanical obstruction, indicated the presence of NR. The HAT2CH2 score was significantly higher in the NR (+) group compared with the NR (−) group [2.29 ± 1.43 vs 1.46 ± 1.24, p < .001]. In multivariable logistic regression analysis, the HAT2CH2 score [OR = 1.585, p < .001] and SXscore [OR = 1.028, p = .017] were found to be independent predictors of NR. Receiver operating characteristic curve analysis showed that the HAT2CH2 score with a cutoff value of >2 determined NR, with 50.2% sensitivity and 79.4% specificity (AUC = .669, p < .001). In conclusion, the HAT2CH2 score may facilitate risk stratification in estimating NR in STEMI patients undergoing pPCI.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of HAT₂CH₂ Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…Higher B-type natriuretic peptide, high-sensitivity C-reactive protein, and systemic immune inflammation index values were found to be associated with NR. 35,36 Quisi et al 37 determined a close relationship between baseline serum rheumatoid factor and NR phenomenon in patients with acute STEMI. Cheng et al 16 demonstrated higher levels of d -dimer and cystatin C in patients with NR in their study consisting of 218 patients with acute anterior MI.…”

Section: Discussionmentioning

confidence: 99%

The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Abacıoğlu¹,

Yıldırım²,

Koyunsever³

et al. 2021

Angiology

View full text Add to dashboard Cite

The no-reflow (NR) phenomenon is frequently encountered in acute coronary syndrome. We evaluated the association between anticoagulation and risk factors in atrial fibrillation (ATRIA) and modified ATRIA risk scores and NR in ST-elevation myocardial infarction (STEMI). Consecutive patients (n = 551) who underwent primary percutaneous coronary intervention between December 2019 and June 2020 due to STEMI were included. The mean age of the patients was 60.5 ± 10.8 years (n = 369, 67% male). The ATRIA and modified anticoagulation and risk factors in atrial fibrillation-hyperlipidemia, smoking, male (m-ATRIA-HS) scores were calculated. The NR group had higher frequency of diabetes mellitus (DM), serum creatine kinase-MB (CK-MB) levels, and corrected thrombolysis in myocardial infarction frame count (cTFC) ( P = .002, P = .006, and P < .001, respectively). In regression analysis, ATRIA, m-ATRIA-HS, thrombus grade, and cTFC were independent predictors of NR. Age, higher CK-MB, and neutrophil-to-lymphocyte ratio and DM were the other predictors for NR. Pairwise comparison of receiver operating characteristics curve analysis showed that the m-ATRIA-HS (>2, area under curve [AUC]: 0.715) has better performance than ATRIA score (>1, AUC: 0.656), with a P < .022 and z statistics 2.279. In conclusion, ATRIA, especially the m-ATRIA-HS, can be used to evaluate NR risk in STEMI.

show abstract

“…However, the relationship between RF and the prognosis and treatment of ischemic stroke is still not extensively studied. RF has been associated with cardiovascular diseases [ 97 , 98 ], immune complexes (ICs) and complement-mediated inflammation [ 99 ], as well as endothelial dysfunction [ 29 ]. Positive RF status has been linked to increased risks and poor prognosis of cardiovascular diseases [ 53 , 100 – 104 ].…”

Section: Rheumatoid Factor and Il-6 Inhibition In Ischemic Stroke: Cu...mentioning

confidence: 99%

Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care

Al-Ewaidat,

Naffaa

2024

Clin Exp Med

View full text Add to dashboard Cite

Rheumatoid arthritis (RA) can independently increase the risk of stroke, affecting both young and adult RA patients. Recent attention has been drawn to the association between stroke and RA, supported by mounting evidence. Given that stroke is a significant and an urgent public health concern, this review aims to highlight the relationship between stroke and RA, covering mechanisms, underlying risk factors, early detection tools, and treatment implications. By uncovering the connection that links RA to stroke, we can pave the way for targeted healthcare practices and the development of preventive strategies for individuals with RA. Therefore, further research is imperative to deepen our understanding of this association and, ideally, guide treatment decisions for individuals at risk of both RA and stroke.

show abstract

The relationship between serum rheumatoid factor level and no‐reflow phenomenon in patients with acute ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Abstract: Baseline serum RF concentrations are independently associated with the no-reflow phenomenon in patients undergoing primary PCI for acute STEMI.

Cited by 6 publications

References 41 publications

Impact of HAT₂CH₂ Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

Impact of HAT₂CH₂ Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care

Contact Info

Product

Resources

About

The relationship between serum rheumatoid factor level and no‐reflow phenomenon in patients with acute ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Abstract: Baseline serum RF concentrations are independently associated with the no-reflow phenomenon in patients undergoing primary PCI for acute STEMI.

Cited by 6 publications

References 41 publications

Impact of HAT2CH2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

Impact of HAT2CH2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care

Contact Info

Product

Resources

About

Impact of HAT₂CH₂ Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

Impact of HAT₂CH₂ Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction